Thyroid hormone receptor isoform expression in livers of critically ill patients.

OBJECTIVE The THRA gene encodes two isoforms of the thyroid hormone receptor (TR), TRalpha1 and TRalpha2. The ratio of these splice variants could have a marked influence on T3-regulated gene expression, especially during illness. DESIGN We studied the expression of the isoforms TRbeta1, TRalpha1, and TRalpha2 and 5'-deiodinase in postmortem liver biopsies of 58 patients who were critically ill and died in the intensive care unit (ICU). All mRNA levels were determined using real-time PCR. MAIN OUTCOME All ratios of the biopsies were higher than those found in three normal liver biopsies due to an increased TRalpha1 level. The TRalpha1/TRalpha2 ratio increased with age and severity of illness following the equation: TRalpha1/TRalpha2 ratio = - 1.854 + (0.0323 x age) + (0.0431 x Therapeutic Intervention Scoring System score) indicating that 28% of the changed TRalpha1/TRalpha2 ratio can be predicted by these clinical variables. There was no effect of randomization to intensive insulin therapy or glucocorticoid or thyroid hormone treatment on the TRalpha1/TRalpha2 ratio or TRbeta1. Furthermore, no relation was seen between the expression levels of the 5'-deiodinase mRNA and TR isoforms or the triiodothyronine T3 levels. CONCLUSION It appears that in critically ill patients the ratio of TRalpha1/TRalpha2 expression increases with age and severity of illness, possibly indicating a mechanism to enhance sensitivity to T3 in the oldest and sickest patients.

[1]  W. Wiersinga,et al.  Contributions of cytokines to nonthyroidal illness , 2006 .

[2]  G. Van den Berghe,et al.  Tissue thyroid hormone levels in critical illness. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  G. Van den Berghe,et al.  Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  G. Van den Berghe,et al.  Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. , 2004, Endocrinology.

[5]  W. Wiersinga,et al.  Triiodothyronine affects the alternative splicing of thyroid hormone receptor alpha mRNA. , 2003, The Journal of endocrinology.

[6]  G. Van den Berghe,et al.  Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.

[7]  K. Feingold,et al.  Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. , 2003, American journal of physiology. Endocrinology and metabolism.

[8]  G. Berghe Dynamic neuroendocrine responses to critical illness , 2002, Frontiers in Neuroendocrinology.

[9]  Stefan Stamm,et al.  Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. , 2002, Human molecular genetics.

[10]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[11]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[12]  E. Ferrari,et al.  Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. , 2002, Metabolism: clinical and experimental.

[13]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[14]  T. Visser,et al.  Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. , 2001, Endocrine reviews.

[15]  C. Wilson,et al.  A purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNA. , 2001, RNA.

[16]  B. Amir-Ahmady,et al.  Regulation of the Processing of Glucose-6-phosphate Dehydrogenase mRNA by Nutritional Status* , 2001, The Journal of Biological Chemistry.

[17]  Distinct Tissue-Specific Roles for Thyroid Hormone Receptors β and α1 in Regulation of Type 1 Deiodinase Expression , 2001 .

[18]  A. Krainer,et al.  Selection of Alternative 5′ Splice Sites: Role of U1 snRNP and Models for the Antagonistic Effects of SF2/ASF and hnRNP A1 , 2000, Molecular and Cellular Biology.

[19]  G. Van den Berghe,et al.  Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.

[20]  J. Manley,et al.  Phosphorylation–dephosphorylation differentially affects activities of splicing factor ASF/SF2 , 1998, The EMBO journal.

[21]  W. Wiersinga,et al.  Expression of the alpha 1, alpha 2, and beta 1 T3-receptor mRNAs in the fasted rat measured using competitive PCR. , 1998, Biochemical and biophysical research communications.

[22]  E. Fliers,et al.  Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.

[23]  K. Yasuda,et al.  Insulin regulated PKC isoform mRNA in rat adipocytes. , 1996, Diabetes research and clinical practice.

[24]  W. Schaufeli,et al.  Simplified Therapeutic Intervention Scoring System: the TISS-28 items--results from a multicenter study. , 1996 .

[25]  A. Kosaki,et al.  Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. , 1993, The Journal of biological chemistry.

[26]  J. Franklyn,et al.  THYROID HORMONE RECEPTOR EXPRESSION IN THE "SICK EUTHYROID" SYNDROME , 1989, The Lancet.

[27]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[28]  D. Cullen,et al.  Therapeutic Intervention Scoring System: Update 1983 , 1983, Critical care medicine.

[29]  T. Visser,et al.  Radioimmunoassay of reverse tri-iodothyronine. , 1977, The Journal of endocrinology.

[30]  D. Cullen,et al.  Therapeutic intervention scoring system: a method for quantitative comparison of patient care. , 1974 .